OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
77
Results
Show all
Save search
Copy query
Show results for
Unknown
(73)
Transcriptomics
(2)
Proteomics
(2)
Organisms
Homo sapiens
(2)
Alphavirus
(2)
Anemia
(2)
Archaea
(2)
Bacteria
(2)
Betaherpesvirinae
(2)
Borrelia
(2)
Chlamydomonas reinhardtii
(2)
Chlorella vulgaris
(2)
Clostridium perfringens
(2)
Dengue virus
(2)
Eukaryota
(2)
Hepatitis B virus
(2)
Human alphaherpesvirus 1
(2)
Human betaherpesvirus 5
(2)
Influenza A virus
(2)
Influenza C virus
(2)
Japanese encephalitis virus group
(2)
Kamptonema sp.
(2)
Listeria monocytogenes
(2)
Mammarenavirus
(2)
Miscanthus x giganteus
(2)
Mycobacterium tuberculosis
(2)
Orthoflavivirus
(2)
Pseudomonas aeruginosa
(2)
Rattus
(2)
Sarbecovirus
(2)
Severe acute respiratory syndrome coronavirus 2
(2)
Staphylococcus aureus
(2)
Streptococcus pneumoniae
(2)
Repository
biostudies-arrayexpress
(2)
pride
(2)
Technology Type
Mass Spectrometry
(2)
Bottom-up proteomics
(1)
Data-independent acquisition
(1)
Gel-based experiment
(1)
Publication Date
2016
(2)
2025
(1)
2022
(1)
Study type
Transcription profiling by array
(1)
Methylation profiling by array
(1)
Release Date
2018
(10)
2021
(9)
2017
(7)
2016
(6)
2023
(6)
2025
(5)
2019
(5)
2024
(4)
2014
(4)
2011
(4)
2022
(3)
2012
(3)
2010
(2)
2020
(1)
2015
(1)
2013
(1)
2009
(1)
2007
(1)
2003
(1)
2001
(1)
Lab affiliation
Cellular Protein Biochemistry Lab Technical University of Munich School of Natural Sciences Department of Bioscience
(1)
Faculty of Chemistry and Biology University of Bremen
(1)
Previous
page
1 / 8
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
8
Next
page
Sort
by:
Relevance
Page size
10
Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors.
Not available
S-EPMC4874232
|
biostudies-literature
Cite
Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518.
Not available
S-EPMC5455764
|
biostudies-literature
Cite
Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904.
Not available
S-EPMC2792952
|
biostudies-literature
Cite
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With
177
Lu-Dotatate in the Phase III NETTER-1 Trial.
Not available
S-EPMC6366953
|
biostudies-literature
Cite
Targeting the mTOR signaling pathway in neuroendocrine tumors.
Not available
S-EPMC4147239
|
biostudies-literature
Cite
Effects of prenatal alcohol exposition on cognitive outcomes in childhood and youth: a longitudinal analysis based on meconium ethyl glucuronide.
Not available
S-EPMC10914883
|
biostudies-literature
Cite
LongBondEliminator: A Molecular Simulation Tool to Remove Ring Penetrations in Biomolecular Simulation Systems.
Not available
S-EPMC9856086
|
biostudies-literature
Cite
Is implicit Theory of Mind real but hard to detect? Testing adults with different stimulus materials.
Not available
S-EPMC6689622
|
biostudies-literature
Cite
Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer.
Not available
S-EPMC4944495
|
biostudies-literature
Cite
Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial.
Not available
S-EPMC4295034
|
biostudies-literature
Cite
Previous
page
1 / 8
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
8
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
